A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay
Brain and Development · 2023
DOI: 10.1016/j.braindev.2023.01.006 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain and Development, 2023. Verfasst von Pınar Özkan Kart und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pediatric Neurology, Farabi Hospital, Karadeniz Technical University, Trabzon, Türkiye. Hauptthemen laut MEDLINE: Nervous System Malformations, Olivopontocerebellar Atrophies, Epilepsies, Myoclonic, Microcephaly. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Pediatric Neurology, Farabi Hospital, Karadeniz Technical University, Trabzon, Türkiye.
- Faculty of Medicine, Department of Medical Genetics, Recep Tayyip Erdogan University, Rize, Türkiye.
- Faculty of Medicine, Department of Pediatric Neurology, Farabi Hospital, Karadeniz Technical University, Trabzon, Türkiye. Electronic address: acansu2011@hotmail.com.
Zitieren
APA
Özkan Kart, P., Citli, S., Yildiz, N., & Cansu, A. (2023). A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay. Brain and Development. https://doi.org/10.1016/j.braindev.2023.01.006
Vancouver
Özkan Kart P, Citli S, Yildiz N, Cansu A. A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay. Brain and Development. 2023. doi:10.1016/j.braindev.2023.01.006
BibTeX
@article{zkanKart2023,
author = {Özkan Kart, Pınar and Citli, Senol and Yildiz, Nihal and Cansu, Ali},
title = {A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay},
journal = {Brain and Development},
year = {2023},
doi = {10.1016/j.braindev.2023.01.006}
}
EUVIMED